Not Yet Recruiting
Phase 2 Study of WGI-0301 Plus Lenvatinib in Patients With Advanced HCC
NCT07540832
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
Not specified
Clinical trial condition
Advanced Hepatocellular Carcinoma (HCC)
Explore clinical trials studying Advanced Hepatocellular Carcinoma (HCC). Study availability and eligibility vary by location and protocol.
20 public trials
10 recruiting studies
Advanced Hepatocellular Carcinoma (HCC) trial results
Not Yet Recruiting
Use of Immune Checkpoint Inhibitors in Patients With Advanced Hepatocellular Carcinoma : Efficacy and Outcomes
NCT07321067
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
- Sohag university hospitals Sohag, Sohag Governorate, Egypt
- sSohag oncology centre Sohag, Sohag Governorate, Egypt
Not Yet Recruiting
Safety and Efficacy of Paclitaxel Liposome Arterial Infusion Combined With Systemic Therapy for Second-Line Treatment of Advanced Liver Cancer
NCT07282509
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
Not specified
Not Yet Recruiting
Effect of Prehabilitation During the Conversion Therapy on Postoperative Outcomes in Unresectable Hepatocellular Carcinoma
NCT06749678
- Conditions
- Advanced Hepatocellular Carcinoma (HCC), Prehabilitation
- Locations
-
- Sun Yat-sen Memorial Hospital Guangzhou, Guangdong, China
NCT04723004
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
- The First Affiliated Hospital of Bengbu Medical college Bengbu, Anhui, China
- Anhui Cancer Hospital Hefei, Anhui, China
- Anhui Provincial Hospital Hefei, Anhui, China
- The Second Hospital of Anhui Medical University Hefei, Anhui, China
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
- Beijing Cancer hospital Beijing, China
NCT02906397
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
Completed
The Safety and Maximum Tolerated Dose of Axitinib in Combination With Radiotherapy for HCC
NCT02814461
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
- Shin Kong Wu Ho-Su Memorial Hospital Taipei, Taiwan
Active, Not Recruiting
Phase III Study of Toripalimab（JS001） Combined With Lenvatinib for Advanced HCC
NCT04523493
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
- Qinhuai Medical Area, General Hospital of PLA Eastern Theater Command Nanjing, Jiangsu, China
- Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico,Oncologia Medica Milan, Italy
- IRCCS Fondazione Giovanni Pascale, Istituto Nazionale Dei Tumori Naples, Italy
- Azienda Ospedaliero Universitaria Pisana Pisa, Italy
Active, Not Recruiting
A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
NCT04344158
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
- The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
- Anhui Provincial Hospital Hefei, Anhui, China
- The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
- Anhui Provincial Cancer Hospital Hefei, Anhui, China